Zacks Research upgraded shares of Elekta (OTCMKTS:EKTAY – Free Report) from a strong sell rating to a hold rating in a research report sent to investors on Tuesday morning,Zacks.com reports. Elekta Stock Up 0.5%Shares of Elekta stock opened at $4.99 on Tuesday. Get Elekta alerts:Elekta (OTCMKTS:EKTAY – Get Free Report) last released its quarterly earnings data on Thursday, May 28th. Elekta Company ProfileElekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Read MoreReceive News & Ratings for Elekta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta and related companies with MarketBeat.com's FREE daily email newsletter.